Daiichi Sankyo Reverse Pitch for Research Colloboration

The Embassy of Canada to Japan is pleased to host a technology scouting webinar featuring Daiichi Sankyo Co., Ltd. Daiichi Sankyo is a Japanese multinational pharmaceutical company that provides innovative products and services in more than 20 countries around the world including Canada. With more than 100 years of scientific expertise, Daiichi draws upon a rich legacy of innovation and a robust pipeline of promising new medicines to help patients.

Daiichi Sankyo is looking for partners in academia and in industry for joint development of early-stage research in the areas of oncology, neurology, drug delivery, and drug discovery platforms. The webinar will be a valuable opportunity to learn more about the type of technology the company is interested in.

Please join us at either of the two information briefings to learn more about Daiichi Sankyo and their technology scouting targets. Webinar participants will receive a B2B meeting request form after the presentation. Daiichi Sankyo will review the form, and schedule B2B meetings with selected researchers and companies between March 15^th and March 26^th (JST).  In case you are not available for the webinars and wish to send a meeting request form, please contact us.

The webinar will take place twice with the same content. Please choose only one of the two options for registration.

Please send the following information to: TOKYO.health.sante@international.gc.ca by February 18 2021. (EST)

1. Your name
2. Title
3. Organization
4. Contact information (Email)
5. Date that you wish to participate.  (Feb. 23 or Feb. 25)

The Embassy of Canada to Japan will send you a link to the webinar a week prior to the event.